SHINE, newcleo to Partner
SHINE has partnered with newcleo, a developer of advanced nuclear reactors and fuel, to advance innovative technologies for the recycling of used nuclear fuel, the company announced recently. According to…
SHINE has partnered with newcleo, a developer of advanced nuclear reactors and fuel, to advance innovative technologies for the recycling of used nuclear fuel, the company announced recently. According to…
SHINE Technologies’ Ilumira has received Centralized Marketing Authorization in Europe, the company announced today. “For years, our customers have asked for a reliable partner that can deliver both the diagnostic…
NorthStar Medical Radioisotopes and the Low Institute for Therapeutics (LIFT), a non-profit clinical research organization, have entered a strategic collaboration to accelerate the development, manufacturing and clinical translation of Lu177-LT17,…
NorthStar Medical Radioisotopes has entered into a multi-year strategic services agreement with QSA Global, which specializes in radioactive source manufacturing and medical radiochemical services, the company announced today. According to…
Forward BIOLABS will be accepting applications for Round 2 of its Innovation to Commercialization Pipeline (ICP) Program between May 26 and June 19, the company announced recently. ICP will continue…
FUJIFILM Cellular Dynamics Inc. (FCDI) opened its new headquarters and iPSC development and manufacturing facility at 8402 Excelsior Dr. on Tuesday, the company announced recently. According to a release, the…
BioForward Wisconsin CEO Lisa Johnson is set to retire at the end of 2026, the organization announced recently. Johnson has been the CEO for the past 11 years and played…
Cellectar Biosciences announced updated and mature 12-month follow-up data from its Phase 2b CLOVER WaM clinical trial evaluating iopofosine I 131 in patients with relapsed or refractory Waldenstrom macroglobulinemia, the…
Elephas is collaborating with Mithrl, an AI company focused on accelerating research through its Scientific Decision Engine (SDE), the company announced recently. “Partnering with Mithrl enables us to more fully…
Northstar Medical Radioisotopes received notice of U.S. Food & Drug Administration (FDA) acceptance of its Type II Drug Master File (DMR) submission for the company’s no-carrier-added (n.c.a.) Actinium-225 (Ac-225), the…